Four period study with four treatment [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2008-07-19 00:22 (6552 d 15:20 ago) – Posting: # 2060
Views: 6,268

Dear Atish!

❝ [...] a four period crossover BE Study with four treatments R1, R2 and T1, T2 comparing R1 with T1 and R2 with T2 separately.

❝ Randomisation sequence would be defined as follows


+-----+----+----+----+----+

| S/P | 1  | 2  | 3  | 4  |

+-----+----+----+----+----+

|  A  | R1 | T1 | R2 | T2 |

|  B  | T1 | R1 | T2 | R2 |

|-----+----+----+----+----+


I guess you 'harvested' the layout from this post dealing with a 4×4×4 Williams's design? :-D

+-----+---+---+---+---+
| S/P | 1 | 2 | 3 | 4 |
+-----+---+---+---+---+
|  1  | D | C | A | B |
|  2  | A | D | B | C |
|  3  | B | A | C | D |
|  4  | C | B | D | A |
+-----+---+---+---+---+


❝ Kindly let me is it correct to conclude Bioequivalence by comparing R1

❝ with T1 and R2 with T2 as if there were two periods.


I highlighted the important point: [...] as if [...].
There's no 'as-if-evaluation'; you should design and evaluate the study properly.

Your design is not balanced any more (T1/R1 only in periods 1/2, T2/R2 only in periods 3/4). Since any sequence effect can only be avoided by design (single dose, no endogenous compound, sufficient washout, no pre-dose concentrations in periods >1), you may run into questions by assessors. In a Williams' design every treatment is preceeded by all other treatments and is administered once as the first one. In technical terms such a property is called balanced for treatment and carry-over.
In your design both T2 and R2 are never administered in period 1 (to the 'treatment-naïve' subject). You may get nasty questions - because obviously in the evaluation you want to split the design into two separate 2×2 'studies':

+-----+----+----+----+----+  #  +-----+----+----+  +  +-----+----+----+
|   actual study layout   |     |    split 1    |     |    split 2    |
+-----+----+----+----+----+     +-----+----+----+     +-----+----+----+
| S/P | I  | II | III| IV |     | S/P | I' | II'|     | S/P | I" | II"|
+-----+----+----+----+----+     +-----+----+----+     +-----+----+----+
|  1  | R1 | T1 | R2 | T2 |     |  1' | R1 | T1 |     |  1" | R2 | T2 |
|  2  | T1 | R1 | T2 | R2 |     |  2' | T1 | R1 |     |  2" | T2 | R2 |
+-----+----+----+----+----+     +-----+----+----+     +-----+----+----+

Whereas the first split is a conventional 2×2×2 cross-over, the second one only looks like one.
I wouldn't recommend it.
Since you are only interested in T1 vs. R1 and T2 vs. R2, why don't you perform two conventional studies?
The money gained in performing fewer screening/post-study examinations easily can be outweighed by the higher chance of drop-outs (4 periods instead of 2). Furthermore, if you want to submit the study to different countries (let's say the origins of R1,2) you always would have to submit the entire stuff.

If you really want to stay with your design, be prepared for questions anyhow.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
374 visitors (0 registered, 374 guests [including 18 identified bots]).
Forum time: 15:43 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5